Literature DB >> 33158603

Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?

Xue Xing1, Yi Yang1, Jia Shi1, Anying Cheng1, Yanan Wang1, Gang Xu1, Fan He2.   

Abstract

Year:  2020        PMID： 33158603      PMCID： PMC7522631          DOI： 10.1016/j.nefro.2020.07.005

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN： 2013-2514


× No keyword cloud information.
  10 in total

1.  Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care.

Authors:  Timo Wolf; Gerrit Kann; Stephan Becker; Christoph Stephan; Hans-Reinhardt Brodt; Philipp de Leuw; Thomas Grünewald; Thomas Vogl; Volkhard A J Kempf; Oliver T Keppler; Kai Zacharowski
Journal:  Lancet       Date:  2014-12-19       Impact factor: 79.321

2.  Blood purification with continuous veno-venous hemofiltration in patients with sepsis or ARDS: a systematic review and meta-analysis.

Authors:  Alessandro Putzu; Ming-Xing Fang; Martina Boscolo Berto; Alessandro Belletti; Luca Cabrini; Tiziano Cassina; Giovanni Landoni
Journal:  Minerva Anestesiol       Date:  2017-06-12       Impact factor: 3.051

3.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.

Authors:  Alexander Zarbock; John A Kellum; Christoph Schmidt; Hugo Van Aken; Carola Wempe; Hermann Pavenstädt; Andreea Boanta; Joachim Gerß; Melanie Meersch
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

4.  Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial.

Authors:  Catherine S C Bouman; Heleen M Oudemans-Van Straaten; Jan G P Tijssen; Durk F Zandstra; Jozef Kesecioglu
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

Review 5.  T cell-mediated immune response to respiratory coronaviruses.

Authors:  Rudragouda Channappanavar; Jincun Zhao; Stanley Perlman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study.

Authors:  Sarah H Alfaraj; Jaffar A Al-Tawfiq; Ayed Y Assiri; Nojoom A Alzahrani; Amal A Alanazi; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2019-03-11       Impact factor: 6.211

7.  Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].

Authors:  Yongshi Yang; Fujun Peng; Runsheng Wang; Ming Yang; Kai Guan; Taijiao Jiang; Guogang Xu; Jinlyu Sun; Christopher Chang
Journal:  J Autoimmun       Date:  2020-05-15       Impact factor: 7.094

8.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

9.  Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.

Authors:  Lang Wang; Wenbo He; Xiaomei Yu; Dalong Hu; Mingwei Bao; Huafen Liu; Jiali Zhou; Hong Jiang
Journal:  J Infect       Date:  2020-03-30       Impact factor: 6.072

Review 10.  Prescription of CRRT: a pathway to optimize therapy.

Authors:  Ayman Karkar; Claudio Ronco
Journal:  Ann Intensive Care       Date:  2020-03-06       Impact factor: 6.925
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.